Our Team – Logix Biosciences

Chris McMahon

PhD (Scientific Advisor)

Chris has been a senior scientist for ManukaMed for over a decade. He completed a PhD at Agresearch, Invermay then completed two postdoctoral positions in the United States at Auburn University and Michigan state, respectively. He spent many years studying the role of growth hormone, IGF-1 and myostatin in regulating post-natal growth.

Jonathan Meeks

Scientific Advisor

Jonathan holds a unique skillset gained over his 30-year career, leading strategic healthcare market development across over twenty countries in multiple segments including Pharma, Medical Devices, Diagnostics and Health IT sectors. His entrepreneurial and innovation expertise in technologic market development and precision medicine have spanned minimally invasive surgery, e-commerce, commercial start ups, professional education, research and development, organization, and people leadership and most recently, leading the establishment of Novartis Oncology, Precision Medicine organization. Jonathan leads the Precision Healthcare Strategies group, in addition to multiple international board of directors advisory roles.

Todd MacLaughlan

Scientific Advisor

Todd is an experienced Pharmaceutical entrepreneurial executive with a 30-year background in Sales, Marketing, Business Development and General management (Bayer, Novartis). His experience includes early-stage genomic activities to drug development and late-stage marketing of global brands, fund raising and start-up experience. His special expertise includes Marketing, Business Development, Licensing, General Management, Strategy, Operations, pharmaceuticals, biotech, product acquisition, Brand and Generic drugs.

Robert (RL) Johnson

VP Regulatory Affairs

Robert (RL) is an experienced and creative regulatory affairs leader, drawing from progressive experience in regulatory strategy and compliance. RL has worked in regulatory affairs for 19 years, in the fields of pharmaceuticals, medical devices, and combination products. Using his CMG background in various therapeutic areas, including sterile injectable, medicinal gases, Class I-exempt through Class Ill medical devices, and biologic dosage forms, RL has established health agency negotiation and complete dossier response management. He has an extensive track record of complete and concise regulatory applications. RL received his MSc in Information Systems and Decisions Sciences from Louisiana State UniversityCompany Advisors

Michael Gentile

VP Medical Affairs

Michael is a clinical practitioner in Respiratory Care Services, Associate Director of Respiratory Care Services, and associate in research at Duke University Medical with extensive experience in the fields of pulmonary medicine. He is a Fellow of the AARC and SCCM and active in critical care and respiratory clinical research. He has 20 years of experience carrying out similar roles for other new and emerging therapeutics.

Amy Broidrick

Board Director

Amy has over 25 years of pharmaceutical strategy and operations experience. She previously served as Director on the Board of Qualigen Therapeutics, a Nasdaq-listed clinical-stage company focused on developing rare cancer therapeutics. Her other roles included President, Qualigen Therapeutics, Sr. Vice President, Global Corporate Development at Viking Therapeutics, and management positions at Merck & Co., including Global Brand Leader with P&L accountability.

Mark Morris

Co-Founder & CFO

Mark is a financial executive with 40+ years of accounting and finance knowledge. He was the long-term owner and operator of Small Business Solutions, Inc., a financial software development company, and is a business strategist for multiple startup companies. He is also the long-term CFO of a non-profit focused on supporting impoverished populations in Peru.

Brett Edmonds

Co-Founder & Vice -President

Brett is an Entrepreneur and Leader in Pharmacology since 1974.

Gavin Gear

Founder & CEO

Gavin Gear Gavin is a results-proven innovator and transformational leader who has launched LogiX based on his previous commercial success in health and wellness products. He has successfully secured multiple partners since founding LogiX Biosciences. He is responsible for overseeing the company’s non-drug products, the drug and medical device development pipeline, and patent design & development.

Management Team

Meet the Innovators Behind Logix Biosciences

Gavin Gear

Founder & CEO

Brett Edmonds

Co-Founder & Vice -President

Mark Morris

Co-Founder & CFO

Amy Broidrick

Board Director

Michael Gentile

VP Medical Affairs

Robert (RL) Johnson

VP Regulatory Affairs

Todd MacLaughlan

Scientific Advisor

Jonathan Meeks

Scientific Advisor

Chris McMahon

PhD (Scientific Advisor)

Contact Us

Quick links

Subscribe for updated

Follow Us

Gavin Gear

Co-Founder & Vice -President